Logo Medical Data Models (MDM) Portal Logo Westfälische Wilhelms-Universität (WWU)
Information:
Error:
en ▾
  • Deutsch
  • English
  • Español
  • Italiano
  • Français
  • Português
  • Svenska
  • Nederlands
  • Login
  • Register
  • Search
  • ODM-XML file upload
  • Create data model
  • ODM-Edit tool
  • Metadata Registry
  • Help
  • About the MDM portal
  • Imprint
  • Login
  • Register

Search through specific fields of a model

The name of the data model contains study:
name:"study"
The description contains two terms:
description:"double blind"
The copyrightholder contains the term UKM:
copyrightholder:"UKM"
The uploader of the model is Martin Dugas:
uploader:"Martin Dugas"
The keywords contain cancer:
keyword:"cancer"

Refine the search with search operators

Search for groups of words with quotes:
"leukemia myeloid"
Use a wildcard to search for prefixes:
NCT*
With AND/OR/NOT find study without eye nor ear:
study AND NOT (eye OR ear)
Cancer must (+) occur, study not (-):
+cancer -study
You may connect the different search techniques:
name:"form*" AND routine
Actions ▾
  • ODM-XML file upload
  • Create data model
  • ODM-Edit tool
  • Metadata Registry
  • About the MDM portal
en ▾
  • Deutsch
  • English
  • Español
  • Italiano
  • Français
  • Português
  • Svenska
  • Nederlands
  • Filter search results
Keywords
Therapeutics ×
Anesthesiology ×
  • Clinical Trial  (7)
  • Sepsis  (7)
  • Vasoconstrictor Agents  (1)
  • Antifungal Agents  (1)
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
  • Select data models
Selected data models

You must log in to select data models for download or further analysis.

7 Search results.

Sort (Relevance) ▾
  • Relevance
  • Rating
  • New first
  • Old first

Eradicate source of infection CandiSep Anesthesiology and Intensive Care NCT02734550 - Eradicate source of infection

- 7/3/18 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: Eradicate source of infection
Study part: Eradicate source of infection Time interval 24 hours before randomization, Time interval after randomization and Day 1 to 14. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.
  • Clinical Trial
  • Anesthesiology
  • Sepsis
  • Therapeutics

Volume Therapy CandiSep Anesthesiology and Intensive Care NCT02734550 - Volume Therapy

- 7/3/18 - 1 form, 1 itemgroup, 5 items, 1 language
Itemgroup: Infusion Therapy
Study part: Volume Therapy Time interval 24 hours before randomization, Time interval after randomization and Day 1 to 14. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.
  • Sepsis
  • Anesthesiology
  • Clinical Trial
  • Therapeutics

Vasopressors and Inotropics CandiSep Anesthesiology and Intensive Care NCT02734550 - Vasopressors and Inotropics

- 7/3/18 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: Vasopressors; inotropics
Study part: Vasopressors and Inotropics Time interval 24 hours before randomization, Time interval after randomization and Day 1 to 14. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.
  • Vasoconstrictor Agents
  • Therapeutics
  • Sepsis
  • Anesthesiology
  • Clinical Trial

Risk factors for invasive Candida infection Screening CandiSep Anesthesiology and Intensive Care NCT02734550 - Risk factors for invasive Candida infection Screening

- 7/3/18 - 1 form, 1 itemgroup, 9 items, 1 language
Itemgroup: Risk Factors; candida infection invasive
Study part: Risk factors for invasive Candida infection Screening. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.
  • Anesthesiology
  • Therapeutics
  • Clinical Trial
  • Sepsis

Antifungal therapy CandiSep Anesthesiology and Intensive Care NCT02734550 - Antifungal therapy

- 6/3/18 - 1 form, 1 itemgroup, 18 items, 1 language
Itemgroup: Antifungal therapy
Study part: Antifungal therapy. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.
  • Sepsis
  • Anesthesiology
  • Antifungal Agents
  • Therapeutics
  • Clinical Trial

Antimicrobial therapy CandiSep Anesthesiology and Intensive Care NCT02734550 - Antimicrobial therapy

- 6/2/18 - 1 form, 1 itemgroup, 13 items, 1 language
Itemgroup: Antimicrobial therapy
Study part: Antimicrobial therapy . (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.
  • Sepsis
  • Clinical Trial
  • Anesthesiology
  • Therapeutics

Adjuvant sepsis therapy CandiSep Anesthesiology and Intensive Care NCT02734550 - Adjuvant sepsis therapy

- 6/2/18 - 1 form, 1 itemgroup, 8 items, 1 language
Itemgroup: Adjuvant therapy Sepsis
Study part: Adjuvant sepsis therapy. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with severe sepsis or septic shock and at high risk of invasive Candida infection (CandiSep). Provided by PD Dr. med. Frank Bloos, Ph.D. Clinic for Anesthesiology and Intensive care, University Clinic Jena.
  • Anesthesiology
  • Therapeutics
  • Sepsis
  • Clinical Trial
  • 1

Contact

Institute of Medical Informatics
Director: Prof. Dr. Martin Dugas
Albert-Schweitzer-Campus 1, A11
48149 Münster, Germany
Email : imi@uni-muenster.de

In collaboration with

Logo DFG Logo ERCIS Logo IMI Logo ESF Logo ULB Logo IH-D Logo Toolpool Logo EFMI
  • Imprint
  • Disclaimer
  • Data Privacy
© 2019  University of Münster
  • Contact
  • Help
  • Cite

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Login

Forgot password?


Register
Sign in with Certificate